Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tideglusib in PSP (TAUROS)
NCT01049399Phase 2Completed
- Sponsor
- Noscira S.A.
- Start
- Dec 2009
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of tideglusib in progressive supranuclear palsy (PSP), sponsored by Noscira S.A.. Started Dec 2009; status: completed.
02
Drugs
tideglusib
03
Conditions
progressive supranuclear palsy (PSP)
Beyond the preview
Go deeper on NCT01049399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01049399.